5 Key Takeaways

• 1

  Myopia is a major global health concern, with the WHO projecting 40% of the population will be affected by 2030.

• 2

  Children are particularly vulnerable to myopia, with increased screen time and reduced outdoor activity during the pandemic exacerbating the issue.

• 3

  MiYOSMART spectacle lenses, utilizing DIMS Technology, have shown to slow myopia progression by 59% and reduce axial elongation by 60%.

• 4

  An 8-year study demonstrated sustained myopia control effects in children wearing MiYOSMART lenses, highlighting the importance of long-term use.

• 5

  Long-term evidence is crucial for informed clinical decisions, ensuring children receive effective, evidence-based care for myopia management.